VitVio is an AI-powered computer vision platform designed to enhance safety, efficiency, and workflow in hospital operating rooms (ORs).[1][2][3] It serves hospitals and surgical teams, particularly in the UK's NHS, by addressing critical inefficiencies like surgical backlogs, wasted OR time (£80 per minute), material waste (£200-900 per procedure), and suboptimal staff allocation amid a 7.8 million waiting list as of 2023.[1] The platform autonomously tracks procedures via cameras and sensors, providing real-time monitoring of surgery progress, tool usage, protocol adherence, inventory management, and workflow optimization, enabling hospitals to boost surgery volumes, cut costs (over £10,000 monthly per OR initially), minimize infection risks, and improve patient outcomes without adding staff burden.[1][2][3]
Growth momentum includes a $2M pre-seed round announced with a partnership at the Royal Orthopaedic Hospital, one of the UK's top institutions for outcomes and efficiency, and a subsequent $8M seed round to scale OR efficiency solutions.[2][4]
VitVio was co-founded by Thomas Knox (CEO), Dr. Peter Rennert (CTO), Maks Kozarzewski (COO), and Aleks Pajewski (CPO), a team with deep expertise in computer vision and AI from over 150 deployments at autonomous retail leaders AiFi and Standard AI.[2] Drawing parallels from revolutionizing retail efficiency, they pivoted this technology to tackle hospital OR inefficiencies, emerging amid the NHS's post-2020 surge in surgical demand and declining performance.[1][2] Early traction came via integration with the Royal Orthopaedic Hospital, leveraging non-intrusive AI for real-time tracking and alerts, as highlighted by CEO Thomas Knox.[2] Backed by LDV Capital, founded in 2012 with a focus on computer vision, this marked a pivotal leap into healthcare.[2]
VitVio rides the wave of AI and computer vision in healthcare, applying proven retail autonomy tech to ORs amid NHS crises like £4.5B annual surgery spend (4% of budget) and persistent 18-week wait misses since 2016.[1][2] Timing aligns with post-pandemic backlogs and demands for non-intrusive tech, as industry experts emphasize, positioning VitVio to influence ecosystem-wide shifts toward AI-optimized perioperative care.[1][2] Market forces like rising costs (£80/minute OR waste) and labor shortages favor it, enabling more procedures, fewer readmissions, and data insights that ripple to policy and efficiency standards across 3,000+ UK ORs and beyond.[1][3]
VitVio is primed to scale post-$8M seed, expanding AI-driven OR platforms to more hospitals, potentially halving waste and accelerating backlog clearance while enhancing global surgical safety.[2][4] Trends like AI integration in medtech, regulatory pushes for efficiency, and computer vision maturity will propel it, evolving its influence from UK pioneer to broader healthcare transformer—tying back to its core mission of doing more surgeries with less, safely.
VitVio has raised $10.0M in total across 2 funding rounds.
VitVio's investors include AngelList Syndicator, Earlybird Venture Capital, LDV Capital, Zehan Wang, Air Street Capital, Andreessen Horowitz, Insight Partners, Alexandre Dalyac, Alex Kayyal.
VitVio has raised $10.0M across 2 funding rounds. Most recently, it raised $8.0M Seed in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $8.0M Seed | AngelList Syndicator, Earlybird Venture Capital, LDV Capital, Zehan Wang | |
| Mar 1, 2024 | $2.0M Seed | Air Street Capital, Andreessen Horowitz, AngelList Syndicator, Earlybird Venture Capital, Insight Partners, LDV Capital, Alexandre Dalyac, Alex Kayyal, Zehan Wang |
